Involvement of interleukin-21 in the pathophysiology of aplastic anemia

European Journal of Haematology
Jizhou ZhangYizhou Zheng

Abstract

Recently enhanced T-helper type 17 (Th17) immune responses and deficient CD4(+) CD25(hi) FoxP3(+) regulatory T cells (Tregs) have been reported in acquired aplastic anemia (AA). Interleukin-21 (IL-21), a CD4(+) T-cell-derived proinflammatory cytokine, modulates the balance between Th17 cells and Tregs. However, its role in AA remains unclear. IL-21 gene expression was examined by quantitative real-time PCR. Cytokines in plasma and cell culture supernatants were detected by ELISA. Cytokines-producing T cells and Tregs were evaluated by flow cytometry. IL-21 mRNA levels in circulating CD4(+) T cells and IL-21 levels in blood plasma were markedly increased in patients with newly diagnosed AA. Moreover, elevated IL-21-producing CD4(+) T cells were accompanied by Th17 cells accumulation and Tregs decrease, and correlated with AA activity. In vitro, IL-21 not only inhibited the expression of FoxP3, but also induced the expression of IL-17 in CD4(+) T cells of AA patients. More importantly, we found that T cells within the bone marrow (BM) of AA patients were in a heightened activation state, which may be related to IL-21. Our data suggested a critical role of IL-21 in breaking immune homeostasis in AA by promoting Th17 cells, activat...Continue Reading

References

Dec 22, 1999·British Journal of Haematology·S RizzoF M Gibson
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mari StrengellSampsa Matikainen
May 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mari StrengellTimo Sareneva
Dec 17, 2003·British Journal of Haematology·Nikolaos C GiannakoulasNicholas C Zoumbos
Jan 5, 2005·The Journal of Experimental Medicine·Rong ZengWarren J Leonard
May 12, 2005·Lancet·Robert A Brodsky, Richard J Jones
Jul 1, 2005·American Journal of Hematology·Naresh Kumar TripathyUNKNOWN Vibhuti
Jan 5, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ilaria PelusoGiovanni Monteleone
Jan 15, 2008·International Journal of Laboratory Hematology·Y GuC Xu
Apr 29, 2008·Trends in Immunology·Giovanni MonteleoneThomas T MacDonald
Aug 14, 2009·British Journal of Haematology·Judith C W MarshUNKNOWN British Committee for Standards in Haematology
Jan 5, 2010·Critical Reviews in Oncology/hematology·Jian Ping LiZhong Chao Han
Aug 25, 2010·Blood·Regis Peffault de LatourNeal S Young
May 13, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dietmar Herndler-BrandstetterBeatrix Grubeck-Loebenstein
Jul 5, 2011·The Journal of Allergy and Clinical Immunology·Guillaume GeriDavid Saadoun
Oct 1, 2011·Arthritis Research & Therapy·Sebastian DolffMarc Bijl
Dec 6, 2011·Blood·Shahram KordastiGhulam J Mufti
Mar 24, 2012·Blood·Kesley AttridgeLucy S K Walker
Sep 24, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sue M Liu, Cecile King

❮ Previous
Next ❯

Citations

Jan 16, 2021·International Journal of Molecular Sciences·Valentina GiudiceCarmine Selleri
Aug 19, 2021·Cell Biology International·Mohammad R JavanBahareh Moghimian-Boroujeni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.